Skip to main
ALC

ALC Stock Forecast & Price Target

ALC Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 18%
Buy 36%
Hold 36%
Sell 9%
Strong Sell 0%

Bulls say

Alcon is poised for a positive outlook as it anticipates enhanced top-line growth and solid operating margin expansion moving into FY26. The company's historical patterns suggest a potential boost in sales of Ocular Health products during the allergy season, with expectations for a strong performance of its Pataday brand in early 2026. Additionally, the introduction of new products is expected to drive higher-than-anticipated growth and market share gains, supporting the company's premium valuation through accelerating mid-teen EPS growth.

Bears say

Alcon faces a multitude of risks that may negatively impact its financial performance, including a potentially weaker economy that could hinder growth in over-the-counter (OTC) segments and delays in product rollouts. Furthermore, the company is experiencing increased competition and a weaker-than-expected uptake of new products, which are forecasted to contribute to growth rates falling below the anticipated range of 6% to 8%. Additionally, external factors such as China-based value-based pricing (VBP), tariffs, and foreign exchange headwinds may complicate margin expansion and overall market performance.

ALC has been analyzed by 11 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 36% recommend Buy, 36% suggest Holding, 9% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alcon Inc. - Registered Shares and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alcon Inc. - Registered Shares (ALC) Forecast

Analysts have given ALC a Buy based on their latest research and market trends.

According to 11 analysts, ALC has a Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $89.32, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $89.32, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alcon Inc. - Registered Shares (ALC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.